Naloxone Market To Surpass US$ 884.8 Mn Threshold By 2026 - Coherent Market Insights

SEATTLE - Feb. 23, 2021 - PRLog -- Global Naloxone Market, by Strength (0.4 mg/ml, 1mg/ml, 0.4mg/0.4ml, and 4mg/0.1ml and Others), by Route of Administration (Intranasal, Intramuscular/Subcutaneous, and Intravenous), by Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa)  was valued at US$ 310.2 Mn in 2017, and is projected to exhibit a CAGR of 11.4% over the forecast period (2018 – 2026).

Browse 47 Market Data Tables and 33 Figures spread through 199 Pages and in-depth TOC on Naloxone Market, by Strength (0.4 mg/ml, 1mg/ml, 0.4mg/0.4ml, and 4mg/0.1ml and Others), by Route of Administration (Intranasal, Intramuscular/Subcutaneous, and Intravenous), by Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, and Others),  and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2026

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1804

Increasing prevalence of opioid overdosing in key countries such as the U.S. and Canada is expected to increase demand for naloxone and significantly drive global naloxone market's growth over the forecast period. For instance, according to data published by Centers for Disease Control and Prevention (CDC) in 2018, in the U.S. over 630,000 people died from a drug overdose from 1999 to 2016, and in 2016 around 66% of the 63,600 drug overdose deaths involved an opioid.

In 2017, 47 states and Washington, DC in the U.S. expanded access to naloxone through legislation that permits prescriptions to people who are likely to encounter someone who might take drug overdose. In 2017, Ontario government provided naloxone kits to police and fire departments to manage emergency case of opioid overdose. Government offered naloxone kits to all 61 police services and 447 fire departments in the Ontario.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/naloxone-market-1804

Key Takeaways of the Naloxone Market:

The global naloxone market is expected to exhibit a CAGR of 11.4% over the forecast period (2018 – 2026), owing to frequent product launches, approval, and robust pipeline of novel biopharmaceutical products

Major players operating in the Naloxone Market include Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1804